Saudi Arabia Vaccinates 3 Million against COVID-19

Source: Al-Arabiya

Saudi Arabia has vaccinated more than 3 million people against COVID-19, about 70 percent of those who have registered to receive the jab, Arab News reported.

The Ministry of Health has continued to emphasize the safety and efficacy of coronavirus vaccines, amid queries and doubts that have pushed some in the Kingdom to opt out of getting the jabs.

At Sunday’s press conference ministry spokesman Dr. Mohammed Al-Abd Al-Aly answered a series of frequently asked questions that included the postponement of pregnancy plans until after receiving the jab, blood donation, vaccine-related fatalities, whether the vaccine would be a requirement for travel or Umrah and other topics.

Al-Aly said there were no indications that the vaccines could have any effect on plans to get pregnant and that plans should go forward smoothly. He added that nursing mothers could also take the vaccines safely, while studies continued to be done on the possibility of providing the vaccine to expectant mothers and people in younger age groups.

Blood donors could also donate blood accordingly without any issues, the spokesman told the press conference.

With concerns about blood clots still strong in people’s minds after high-profile cases of foreign governments pausing or altering their vaccination programs over this health concern, Al-Aly reiterated that a causal link between blood clots and the vaccine had not been proven. There was no accurate or strong evidence that would indicate a correlation between the vaccines and thrombosis, he said, and the benefits of the vaccine outweighed the side effects.

On the subject of Umrah and travel, Al-Aly said that the vaccine was for everyone’s safety, especially when large crowds of people were involved, and authorities had not imposed any restrictions on travelers or pilgrims who had not been vaccinated.

For people who have received the vaccine, a post-jab survey on the Sehhaty app allows them to register any symptoms after the first or second dose.
The spokesman confirmed that no serious side effects had been noted other than what was expected — a slight fever, headache, nausea, chills or muscle pain. He  added that no vaccine-related deaths had occurred, rejecting claims that a man had died due to complications after receiving a dose.

Be the first to comment

Leave a Reply

Your email address will not be published.


*